| ≤7 days (N = 888) | >7 days (N = 181) | P |
---|---|---|---|
Demographic data | |||
 Male | 538(60.6) | 129(71.3) | 0.007 |
 Age (year) | 61.3 ± 8.1 | 63.9 ± 8.3 | < 0.001 |
Medical history | |||
 Hypertension | 364(41.0) | 114(63.0) | < 0.001 |
 DM | 116(13.1) | 56(30.9) | < 0.001 |
 NYHA classification 3–4 | 686(77.3) | 118(65.2) | < 0.001 |
Laboratory values | |||
 Hemoglobin (g/L) | 131.5 ± 15.1 | 130.9 ± 141.3 | 0.685 |
 Albumin(g/L) | 40.2 ± 3.5 | 39.8 ± 3.7 | 0.184 |
Kidney function | |||
 Serum creatinine (mg/dl) | 81.9 ± 24.5 | 85.8 ± 25.0 | 0.055 |
 eGFR (ml/min/1.73m2) | 83.8 ± 19.5 | 81.8 ± 20.8 | 0.227 |
 eGFR< 60 ml/min/1.73m2 | 80(9.1) | 24(13.9) | 0.069 |
Angiographic values | |||
 Interval between angiography and surgery (day) | 3.2(1.9) | 9.7(2.7) | < 0.001 |
 aContrast media dose (ml/kg) | 280(231,349) | 285(246,342) | 0.198 |
Surgical data | |||
 Valve | 692(77.2) | 40(22.1) | < 0.001 |
 CABG | 151(17.0) | 131(72.4) | < 0.001 |
 Valve & CABG | 45(5.1) | 10(5.5) | 0.326 |
 CPB | 705(79.4) | 57(31.5) | < 0.001 |
 aCPB time (min) | 100(75,127) | 90(70,119) | 0.106 |
 bErythrocyte transfusion | 441(49.6) | 75(41.4) | 0.149 |
Prognosis | |||
 AKI | 374(42.1) | 38(21.0) | < 0.001 |
 KDIGO 1 | 305(34.3) | 29(16.0) | < 0.001 |
 KDIGO 2 | 45(5.1) | 8(4.5) | 0.286 |
 KDIGO 3 | 24(2.7) | 1(0.6) | < 0.001 |
 RRT | 16(1.8) | 4(2.2) | 0.762 |
 In-hospital mortality | 2(0.2) | 1(0.6) | 0.427 |
 aLength of ICU stay (day) | 40(22,64) | 42(22,70) | 0.861 |
 aLength of hospital stay (day) | 14(11,18) | 12(11,15) | < 0.001 |